Prognosis
Vaccine Trials Seen Resuming; Cases Top 41 Million: Virus Update
This article is for subscribers only.
The U.S. trials of coronavirus vaccines made by AstraZeneca Plc and Johnson & Johnson may resume as soon as next week, according to the head of the Operation Warp Speed program. A participant who died during Astra’s study in Brazil hadn’t received the company’s shot, according to a person familiar with the matter.
New York City is planning for wide-scale distribution of a vaccine next year, and the state reported 2,000 new cases for the first time since May. U.S. hospitalizations for Covid-19 hit the highest point in two months.